Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19
Clinical trial NCT04681079 · COMPLETED
Trial details
- NCT number
- NCT04681079
- Sponsor
- Theravance Biopharma
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-04
- Primary completion
- 2021-11-22
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.